Lite Strategy LITS
NASDAQ LITS
$1.16 -0.03 (-2.52%)
At close: Oct 23, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Non Operating Investment Income (2024)

Updated

Lite Strategy's Non Operating Investment Income came in at $500,000 for FY2025 (year ended Jun 30, 2025).

Analysis

Lite Strategy (LITS) Non Operating Investment Income (2024) Analysis & Trends

  • The FY2025 figure represents the lowest annual Non Operating Investment Income since FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Lite Strategy 40.43 Mn 8.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 500,000.00
API Access

Lite Strategy Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LITS&period=max&api_key=YOUR_API_KEY